Eric Joseph Daniels

This profile gathers the share dealings of Eric Joseph Daniels in Kiora Pharmaceuticals Inc, where the filings describe the role as senior executive. In total, 10 filings cover trades dated from 21 October 2021 to 1 April 2026.

No open-market sale appears; the market trades are 1 purchase worth €7,049. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 9 share grants.

Most recently, on 2 April 2026, the filings show a share grant worth €1,563 in Kiora Pharmaceuticals Inc. The clock since the last published purchase (14 June 2024) now reads 856 days. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.